Amarin Corp Plcuk (AMRN) Preferred Shares Issued (2015)
Amarin Corp Plcuk (AMRN) reported Preferred Shares Issued of $5.5 million for Q3 2015, up 5404.81% quarter-over-quarter from -$104000.0 in Q2 2015.
Amarin Corp Plcuk (AMRN) Preferred Shares Issued (2015) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 1 years of Preferred Shares Issued data on file, last reported at $5.5 million in Q3 2015.
- Preferred Shares Issued for Q3 2015 came in at $5.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $57.7 million (changed N/A YoY), and the FY2015 annual result was $57.7 million, changed N/A from the prior year.
- Preferred Shares Issued advanced to $5.5 million in Q3 2015 per AMRN's latest filing, from -$104000.0 in the prior quarter.
- Over five years, Preferred Shares Issued peaked at $52.3 million in Q1 2015 and troughed at -$104000.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | - |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 5.52 Mn |
| Sep 30, 2015 | 5.52 Mn |
| Jun 30, 2015 | -104,000.00 |
| Jun 30, 2015 | -104,000.00 |
| Mar 31, 2015 | 52.25 Mn |
| Mar 31, 2015 | 52.25 Mn |